Search
Close
Search
Advanced Search
Search Menu
AI Discovery Assistant

We evaluated the effect of chronic clonidine administration on 24-h integrated GH secretion (IC-GH) in eight children (six boys and two girls; age, 6.0–13.0 yr) with constitutional growth delay (CGD). Clonidine was given orally in a daily dose of 0.1 mg/m2 at bedtime for 6 months; 24-h secretion studies were performed before and after 2 months of treatment. Clonidine caused a significant augmentation (P < 0.02) of mean IC-GH from 2.6 ± 0.4 (±se) to 4.6 ± 0.6 μg/L. The increase in IC-GH was mainly the result of increased GH pulse amplitude, which rose from 12.3 ± 1.3 to 18.2 ± 2.1 μg/L (P < 0.01). The mean GH pulse amplitude was significantly higher (P < 0.02) during sleep (15.9 ± 2.4 μg/L) than during the awake hours (8.4 ± 1.5 μg/L) before treatment. During clonidine treatment the mean GH pulse amplitude during the awake hours (15.0 ± 3.8 μg/L) was similar to that during sleep (20.3 ± 3.1 μg/L). GH pulse frequency was not altered by treatment during either the awake or sleep hours. The mean insulin-like growth factor I levels after 2 (1400 ± 300 U/L) and 6 (1760 ± 430 U/L) months of treatment were significantly higher (P < 0.02 and P < 0.05, respectively) than the pretreatment value (920 ± 240 U/L). After 2 months of clonidine treatment, growth velocity increased from 3.1 ± 0.5 to 10.2 ± 1.0 cm/yr (P < 0.001), and after 6 months of treatment is was still significantly higher (7.0 ± 0.7 cm/yr; P < 0.02) than that before treatment. These results confirm the ability of clonidine to accelerate growth in children with CGD and indicate that clonidine is capable of increasing IC-GH levels. They also reinforce the view that many children with CGD have decreased endogenous GH secretion

This content is only available as a PDF.
Copyright © 1989 by The Endocrine Society
Issue Section:
Articles
You do not currently have access to this article.
Download all slides